Theriva Biologics (TOVX) Revenue & Revenue Breakdown
Theriva Biologics Revenue Highlights
00
Theriva Biologics Revenue by Period
Theriva Biologics Revenue by Year
Date | Revenue | Change |
---|---|---|
2023-12-31 | - | 100.00% |
2022-12-31 | - | 100.00% |
2021-12-31 | - | 100.00% |
2020-12-31 | - | 100.00% |
2019-12-31 | - | 100.00% |
2018-12-31 | - | 100.00% |
2017-12-31 | - | 100.00% |
2016-12-31 | - | 100.00% |
2015-12-31 | - | 100.00% |
2014-12-31 | - | 100.00% |
2013-12-31 | - | 100.00% |
2012-12-31 | - | 100.00% |
2011-12-31 | - | -100.00% |
2010-12-31 | $3.16M | 2969.69% |
2009-12-31 | $103.09K | 100.00% |
2008-12-31 | - | 100.00% |
2007-12-31 | - | 100.00% |
2006-12-31 | - | 100.00% |
2005-12-31 | - | -100.00% |
2002-12-31 | $10.00K | -98.86% |
2001-12-31 | $874.10K | 72.55% |
2000-12-31 | $506.57K | 26.84% |
1999-12-31 | $399.38K | -0.16% |
1998-12-31 | $400.00K | -20.00% |
1997-12-31 | $500.00K | - |
1996-12-31 | $500.00K | 400.00% |
1995-12-31 | $100.00K | - |
1994-12-31 | $100.00K | - |
1993-12-31 | $100.00K | - |
Theriva Biologics Revenue by Quarter
Date | Revenue | Change |
---|---|---|
2024-03-31 | - | -100.00% |
2023-12-31 | $758.00K | 100.00% |
2023-09-30 | - | 100.00% |
2023-06-30 | - | 100.00% |
2023-03-31 | - | 100.00% |
2022-12-31 | - | 100.00% |
2022-09-30 | - | 100.00% |
2022-06-30 | - | 100.00% |
2022-03-31 | - | 100.00% |
2021-12-31 | - | 100.00% |
2021-09-30 | - | 100.00% |
2021-06-30 | - | 100.00% |
2021-03-31 | - | 100.00% |
2020-12-31 | - | 100.00% |
2020-09-30 | - | 100.00% |
2020-06-30 | - | 100.00% |
2020-03-31 | - | 100.00% |
2019-12-31 | - | 100.00% |
2019-09-30 | - | 100.00% |
2019-06-30 | - | 100.00% |
2019-03-31 | - | 100.00% |
2018-12-31 | - | 100.00% |
2018-09-30 | - | 100.00% |
2018-06-30 | - | 100.00% |
2018-03-31 | - | 100.00% |
2017-12-31 | - | 100.00% |
2017-09-30 | - | 100.00% |
2017-06-30 | - | 100.00% |
2017-03-31 | - | 100.00% |
2016-12-31 | - | 100.00% |
2016-09-30 | - | 100.00% |
2016-06-30 | - | 100.00% |
2016-03-31 | - | 100.00% |
2015-12-31 | - | 100.00% |
2015-09-30 | - | 100.00% |
2015-06-30 | - | 100.00% |
2015-03-31 | - | 100.00% |
2014-12-31 | - | 100.00% |
2014-09-30 | - | 100.00% |
2014-06-30 | - | 100.00% |
2014-03-31 | - | 100.00% |
2013-12-31 | - | 100.00% |
2013-09-30 | - | 100.00% |
2013-06-30 | - | 100.00% |
2013-03-31 | - | 100.00% |
2012-12-31 | - | 100.00% |
2012-09-30 | - | 100.00% |
2012-06-30 | - | 100.00% |
2012-03-31 | - | -100.00% |
2011-12-31 | $-972.12K | -431.31% |
2011-09-30 | $293.42K | -17.48% |
2011-06-30 | $355.56K | 10.03% |
2011-03-31 | $323.14K | -47.85% |
2010-12-31 | $619.69K | 113.76% |
2010-09-30 | $289.90K | -86.79% |
2010-06-30 | $2.19M | 3555.77% |
2010-03-31 | $60.04K | 15.45% |
2009-12-31 | $52.00K | 1.80% |
2009-09-30 | $51.09K | 100.00% |
2009-06-30 | - | 100.00% |
2009-03-31 | - | 100.00% |
2008-12-31 | - | 100.00% |
2008-09-30 | - | - |
Theriva Biologics Peer Comparison by Revenue
Ticker | Company | Last Year Revenue | Last Quarter Revenue |
---|---|---|---|
FRTX | Fresh Tracks Therapeutics | $8.01M | - |
MRKR | Marker Therapeutics | $3.31M | $1.93M |
PRAX | Praxis Precision Medicines | $2.45M | $302.00K |
SABS | SAB Biotherapeutics | $2.24M | $263.14K |
LUMO | Lumos Pharma | $2.05M | $488.00K |
AVTX | Avalo Therapeutics | $1.41M | - |
CBIO | Gyre Therapeutics | $794.00K | - |
VCNX | Vaccinex | $570.00K | $52.00K |
BDRX | Biodexa Pharmaceuticals | $381.00K | $41.50K |
XCUR | Exicure | - | - |
TOVX | Theriva Biologics | - | - |
LSTA | Lisata Therapeutics | - | - |
REVB | Revelation Biosciences | - | - |
KTRA | Kintara Therapeutics | - | $76.00K |
FWBI | Entero Therapeutics | - | - |
GOVX | GeoVax Labs | - | $300.68K |
PMVP | PMV Pharmaceuticals | - | - |
VRPX | Virpax Pharmaceuticals | - | - |
PTIX | Protagenic Therapeutics | - | $50.29K |
SLRX | Salarius Pharmaceuticals | - | - |
DFFN | CervoMed | - | - |